BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

QIAGEN Inc. 

27220 Turnberry Lane
Suite 200
Valencia  California  91355  U.S.A.
Phone: 800-718-2056 Fax: n/a


SEARCH JOBS


QIAGEN N.V., a Netherlands holding company, is the leading global provider of sample and assay technologies. Sample technologies are used to isolate and process DNA, RNA and proteins from biological samples such as blood or tissue. Assay technologies are used to make such isolated biomolecules visible. QIAGEN has developed and markets more than 500 sample and assay products as well as automated solutions for such consumables. The company provides its products to molecular diagnostics laboratories, academic researchers, pharmaceutical and biotechnology companies, and applied testing customers for purposes such as forensics, animal or food testing and pharmaceutical process control. QIAGEN's assay technologies include one of the broadest panels of molecular diagnostic tests available worldwide. This panel includes the digene HPV Test, which is regarded as the "gold standard" in testing for high-risk types of human papillomavirus (HPV), the primary cause of cervical cancer. The company employs more than 3,100 people in over 30 locations worldwide. QIAGEN’s North American headquarters is in Germantown, Maryland and its global headquarters is located in Hilden, Germany.

Further information about QIAGEN can be found at http://www.qiagen.com/.


 Key Statistics


Email: customercare-us@qiagen.com
Ownership:

Web Site: QIAGEN Inc.
Employees: 210
Symbol: QGEN
 









 Company News
FDA Clears QIAGEN Inc. (QGEN)'s QIAsymphony RGQ MDx System For C. Difficile 5/5/2014 3:22:36 PM
QIAGEN Inc. (QGEN) To Depart Old Headquarters, Expand Two Other Maryland Campuses 4/16/2014 7:20:26 AM
Maverix Strengthens Strategic Co-Marketing Alliance With QIAGEN Inc. (QGEN) 4/2/2014 11:25:20 AM
QIAGEN Inc. (QGEN) Launches New-Gen TB Test In China 3/21/2014 12:05:24 PM
First SYGNIS Pharma AG QualiPhi® -Based Products Launched By QIAGEN Inc. (QGEN) 2/12/2014 1:36:29 PM
Exosome Diagnostics And QIAGEN Inc. (QGEN) Expand Collaboration To Develop Non-Invasive Biofluid Diagnostic For Lung Cancer 1/13/2014 10:38:47 AM
Maverix Biomics Forms Strategic Co-Marketing Alliance With QIAGEN Inc. (QGEN) 11/13/2013 11:37:57 AM
QIAGEN Inc. (QGEN) Picks Up New Cancer Biomarkers in Two Deals 5/31/2013 9:13:06 AM
QIAGEN Inc. (QGEN) and BioBay Announce Translational Medicine JV 5/29/2013 8:58:39 AM
IntelligentMDx Enters into an Agreement With QIAGEN Inc. (QGEN) to Develop Molecular Tests 1/8/2013 9:23:12 AM
12345678910